Utah Medical Products, Inc. (UTMD) return on equity (ROE)

Return on equity · fiscal 2025
9.5%

Utah Medical Products, Inc. (UTMD) earned a return on equity of 9.5% in fiscal 2025 (the year ended December 31, 2025). That is 2.4 percentage points lower than the 11.8% of fiscal 2024. Figures as of 17 Nov 2026, 19:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
9.5%
Change on fiscal 2024
−2.4 pts
Highest on record
20.9%fiscal 2018
Lowest on record
9.5%fiscal 2025
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Utah Medical Products, Inc. return on equity (ROE), in more detail

Across the 16 fiscal years on record (2010–2025), the highest was 20.9% in fiscal 2018 and the lowest 9.5% in fiscal 2025. The fiscal 2025 figure is no higher than in any of the 15 earlier fiscal years on record, whose median is 15.9%.

History · 16 fiscal years

Return on equity by fiscal year

Utah Medical Products, Inc. return on equity (ROE), year by year

Utah Medical Products, Inc. (UTMD) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
20259.5% 2.4 pts down
202411.8% 1.1 pts down
202313.0% 1.5 pts down
202214.4% 0.6 pts up
202113.8% 3.3 pts up
202010.5% 4.1 pts down
201914.6% 6.3 pts down
201820.9% 10.0 pts up
201710.9% 6.6 pts down
201617.5% 0.5 pts up
201517.0% 0.6 pts down
201417.6% 1.2 pts down
201318.8% 1.1 pts down
201220.0% 1.8 pts up
201118.2% 2.3 pts up
201015.9%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on UTMD

Utah Medical Products, Inc., figure by figure

Utah Medical Products, Inc. (UTMD) overview: price, valuation and scorecard

Utah Medical Products, Inc. return on equity (ROE): questions and answers

What is Utah Medical Products, Inc.'s return on equity?

Utah Medical Products, Inc. (UTMD) earned a return on equity of 9.5% in fiscal 2025 (the year ended December 31, 2025). That is 2.4 percentage points lower than the 11.8% of fiscal 2024.

Is Utah Medical Products, Inc.'s return on equity high or low compared with its own history?

The fiscal 2025 figure is no higher than in any of the 15 earlier fiscal years on record, whose median is 15.9%.

What are the highest and lowest return on equity figures on record for Utah Medical Products, Inc.?

Across the 16 fiscal years on record (2010–2025), the highest was 20.9% in fiscal 2018 and the lowest 9.5% in fiscal 2025.

How is Utah Medical Products, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Utah Medical Products, Inc. (UTMD) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/UTMD/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.